Welcome : Guest

Aradigm Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Aradigm Corporation, which is principally involved in Emerging Specialty Pharmaceuticals Business. Illustrated with 15 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-30506
Price: $750
Company Type: Public
Pages: 17
Date: November 2016
Market Data Tables: 15

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Respiratory Drugs......3
Table 1: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......3
Table 2: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......4
Chronic Obstructive Pulmonary Disease (COPD) Drugs......5
Table 3: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......5
Table 4: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......6
Table 5: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......7
Table 6: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......8
Cystic Fibrosis (CF)......9
Table 7: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......9
Smoking Cessation......10
Table 8: Global Smoking Cessation (Nicotine Replacement Therapy & Prescription Drugs) Market (2014) in US$ Million......10
Table 9: Smoking Cessation Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......11
Table 10: Nicotine Replacement Therapy (NRT) Smoking Cessation Market by Product Worldwide (2015) - Percentage Share Breakdown by Value Sales for Gum, Patches, Tablets or Lozenges, and Others......12
Nicotine Replacement Therapy......13
Table 11: Nicotine Replacement Therapy Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Gum, Inhalaors, Lozenges, Patches, and Others......13
Table 12: Nicotine Replacement Therapy (NRT) Products Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Habitrol, Nicoderm CQ, Nicorette, and Nicotrol......14
Table 13: Global NRT (Nicotine Replacement Therapy) Products Market (2014) in US$ Million......15
Table 14: Nicotine Replacement Therapy (NRT) Products Market by Retail Sales in the UK (2015) - Percentage Share Breakdown for Gums, Inhalers/Sprays, Lozenges & Tablets, and Patches......16
Respiratory Therapeutics......17
Table 15: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......17